Titan Historical Income Statement
| TTNP Stock | USD 6.71 0.14 2.04% |
Historical analysis of Titan Pharmaceuticals income statement accounts such as Cost Of Revenue of 106.4 K, Total Operating Expenses of 13 M, Total Other Income Expense Net of 1.8 M or Selling General Administrative of 5.4 M can show how well Titan Pharmaceuticals performed in making a profits. Evaluating Titan Pharmaceuticals income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Titan Pharmaceuticals's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Titan Pharmaceuticals latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Titan Pharmaceuticals is a good buy for the upcoming year.
Titan |
About Titan Income Statement Analysis
Titan Pharmaceuticals Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Titan Pharmaceuticals shareholders. The income statement also shows Titan investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Titan Pharmaceuticals Income Statement Chart
Titan Pharmaceuticals Income Statement is one of the three primary financial statements used for reporting Titan's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Titan Pharmaceuticals revenue and expense. Titan Pharmaceuticals Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Titan Pharmaceuticals' Other Operating Expenses is relatively stable compared to the past year. As of 05/01/2024, Total Operating Expenses is likely to grow to about 13 M, while Total Revenue is likely to drop slightly above 174.8 K. Add Fundamental
Interest Expense
The cost incurred by an entity for borrowed funds, including loans, bonds, or lines of credit.Total Revenue
Total revenue comprises all receipts Titan Pharmaceuticals generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.Total Operating Expenses
The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.Net Interest Income
The difference between the revenue generated from a bank's interest-bearing assets and the expenses associated with paying its interest-bearing liabilities.Most accounts from Titan Pharmaceuticals' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Titan Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Titan Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. To learn how to invest in Titan Stock, please use our How to Invest in Titan Pharmaceuticals guide.At this time, Titan Pharmaceuticals' Other Operating Expenses is relatively stable compared to the past year. As of 05/01/2024, Total Operating Expenses is likely to grow to about 13 M, while Total Revenue is likely to drop slightly above 174.8 K.
Titan Pharmaceuticals income statement Correlations
Click cells to compare fundamentals
Titan Pharmaceuticals Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Titan Pharmaceuticals income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Depreciation And Amortization | (1.1M) | 2.0M | (440K) | 196K | 112K | 106.4K | |
| Interest Expense | 967K | 769K | 1K | (29K) | (33.4K) | (31.7K) | |
| Total Revenue | 3.6M | 4.8M | 1.5M | 60K | 184K | 174.8K | |
| Gross Profit | 2.3M | 4.4M | 1.3M | (136K) | 72K | 68.4K | |
| Other Operating Expenses | 20.5M | 12.2M | 10.9M | 10.3M | 7.5M | 13.0M | |
| Operating Income | (16.8M) | (7.4M) | (9.4M) | (10.2M) | (7.3M) | (7.6M) | |
| Ebit | (16.8M) | (7.4M) | (9.4M) | (10.2M) | (7.3M) | (7.6M) | |
| Ebitda | (17.9M) | (5.3M) | (9.8M) | (10.0M) | (7.2M) | (7.5M) | |
| Cost Of Revenue | 1.3M | 472K | 199K | 196K | 112K | 106.4K | |
| Total Operating Expenses | 19.2M | 11.7M | 10.7M | 10.3M | 7.3M | 13.0M | |
| Income Before Tax | (16.5M) | (7.4M) | (8.8M) | (10.2M) | (5.6M) | (5.8M) | |
| Total Other Income Expense Net | 386K | (56K) | 578K | 29K | 1.7M | 1.8M | |
| Net Income | (16.1M) | (20.7M) | (8.1M) | (10.2M) | (5.6M) | (5.8M) | |
| Income Tax Expense | (369K) | 13.3M | (662K) | (29K) | (33.4K) | (35.0K) | |
| Selling General Administrative | 5.4M | 5.8M | 5.0M | 6.0M | 5.5M | 5.4M | |
| Research Development | 7.2M | 5.9M | 5.7M | 4.8M | 1.9M | 1.8M | |
| Net Income From Continuing Ops | (16.5M) | (7.4M) | (8.8M) | (10.2M) | (6.2M) | (6.5M) | |
| Non Operating Income Net Other | 564K | 128K | 1.4M | 713K | 641.7K | 1.3M | |
| Net Income Applicable To Common Shares | (9.3M) | (16.5M) | (18.2M) | (8.8M) | (7.9M) | (8.3M) | |
| Interest Income | 753K | 143K | 1K | 53K | 5K | 4.8K | |
| Net Interest Income | (967K) | (769K) | 1K | 53K | 45K | 47.3K | |
| Reconciled Depreciation | 244K | 292K | 221K | 196K | 154K | 217.6K |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Titan Pharmaceuticals in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Titan Pharmaceuticals' short interest history, or implied volatility extrapolated from Titan Pharmaceuticals options trading.
Currently Active Assets on Macroaxis
When determining whether Titan Pharmaceuticals is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Titan Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Titan Pharmaceuticals Stock. Highlighted below are key reports to facilitate an investment decision about Titan Pharmaceuticals Stock:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Titan Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. To learn how to invest in Titan Stock, please use our How to Invest in Titan Pharmaceuticals guide.You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Complementary Tools for Titan Stock analysis
When running Titan Pharmaceuticals' price analysis, check to measure Titan Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Titan Pharmaceuticals is operating at the current time. Most of Titan Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Titan Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Titan Pharmaceuticals' price. Additionally, you may evaluate how the addition of Titan Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |
Is Titan Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Titan Pharmaceuticals. If investors know Titan will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Titan Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (7.41) | Revenue Per Share 0.245 | Quarterly Revenue Growth (1.00) | Return On Assets (0.75) | Return On Equity (1.39) |
The market value of Titan Pharmaceuticals is measured differently than its book value, which is the value of Titan that is recorded on the company's balance sheet. Investors also form their own opinion of Titan Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Titan Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Titan Pharmaceuticals' market value can be influenced by many factors that don't directly affect Titan Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Titan Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Titan Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Titan Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.